ABVC BioPharma Receives $70,000 Payment for GMP Facility in Hsinchu
Update: 2025-10-08
Description
ABVC BioPharma has received a total of $566,000 under the ForSeeCon licensing agreement to support the GMP facility for Vitargus® production. The company has received a total of $1,345,950 in licensing revenues in fiscal 2025, enabling strategic reinvestments and growth opportunities in CNS, oncology, and ophthalmology.
Comments
In Channel